Back to search
Arginase I Deficiency
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Arginase I Deficiency trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Arginase I Deficiency trials you may qualify forCAEB1102-300A is a multi-center randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of pegzilarginase in patients with ARG1-D…
This is an open-label, multicenter study to evaluate the safety of weekly SC administration of pegzilarginase over 12 months in subjects with ARG1-D. The study…
The purpose of this study is to investigate the long-term safety, tolerability, immunogenicity, pharmacokinetics and pharmacodynamics of intravenous AEB1102 in…